Medivir announces that the first patient has been enrolled in the company’s phase I/II study of birinapant in combination with the anti-PD-1 therapy KEYTRUDA (pembrolizumab), which is marketed by MSD.
Professor Borrebaeck has been awarded the Swedish BiotechBuilders award 2017. Borrebaeck is a professor at Lunds University, an entrepreneur and co-founder of the Medicon Valley Alliance Oncology Network. The award is
Temple University Health System (TUHS) will install Sectra PACS throughout their multi-hospital system. Sectra’s imaging solution will provide an integrated master patient index with linking capabilities and by joining an unlimited number
Moberg Pharma announces that the Canadian Patent Office has issued Patent No. 2 860 373 which protects BUPI, currently in development for pain due to oral mucositis. The Canadian patent
The Russian biotechnology company BIOCAD will invest an initial €25 million in establishing the facility in Turku, and launch research co-operation with the University of Turku and Åbo Akademi University.
The pharma giant was recently granted a patent on their vaccine for pneumonia in India, which has been highly questioned by for example Medecins sans Frontiers (MSF). The patent approval
Researchers at Chalmers University of Technology and the University of Gothenburg have found several new genes that make bacteria resistant to last-resort antibiotics. The genes were found by searching large
In Focus – Entrepreneurs
BioArctic announces that the European Patent Office (EPO) has decided to grant a European patent (EP2539366) to BioArctic AB and the patent will be published on November 08, 2017. The European
New Innovation and Design
BONESUPPORT announces that a pre-clinical study evaluating the in-vivo release kinetics of radio-labelled bone morphogenic protein (rhBMP-2) and zoledronic acid (ZA) from CERAMENT BONE VOID FILLER (BVF) was presented at
The first patient in the CANFOUR clinical trial has received three cycles of treatment with the antibody CAN04 and thereby, the first patient has formally completed the safety evaluation period
The company’s marketing authorization application (MAA) for the investigational, weekly and monthly CAM2038 buprenorphine depots for the treatment of opioid dependence has been fully validated by the European Medicines Agency.
Careers – On A New Job
Moberg Pharma appoints Torbjörn Wärnheim, Director Pharmaceutical Innovation and Development, as a member of Moberg’s Management Team. Wärnheim has had
Sedana Medical announces the recruitment of Peter Sackey, MD, PhD as Chief Medical Officer (CMO). Sackey has over twenty years’
Annexin Pharmaceuticals has appointed Jamal El-Mosleh as new CEO of the company, and he started his new position on October
OxThera announces the appointment of Dr. Bastian Dehmel as their new Chief Medical Officer. Dehmel joins OxThera after serving as Executive Medical Director and
BONESUPPORTTM has appointed Helena L Brandt as its new Head of Human Resources. Her appointment is to meet the demands
Hanna Kotola, Vice President of Legal Affairs, has been appointed to undertake the wider role of Quality & Regulatory Affairs,
Dr Paula Salmikangas, former chair of EMA Committee for Advanced Therapies (CAT), has joined the NDA Advisory Board as Director of
SwedenBIO has appointed Helena Strigård as deputy CEO and Head of Policy. The national non-profit association for the life science
Teva Pharmaceutical Industries has announced that its Board of Directors has named Kåre Schultz to become the company’s President and
AstraZeneca’s Innovative Medicines and EarlyDevelopment (IMED) Biotech Unit has appointed Professor Maria Belvisi as Vice President and Head of Respiratory,